COMMUNIQUÉS West-GlobeNewswire

American Oncology Network Announces the Research Studies Presented at the ASCO 2024 Annual Meeting
04/06/2024
AON physicians and leaders present their latest cancer findings with fellow thought leaders at the annual conference. FORT MYERS, Fla., June 04, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (Nasdaq: AONC), [...]
STRATA Skin Sciences to Participate in June Dermatology Conferences
04/06/2024
HORSHAM, Penn., June 04, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]
Cyclacel’s Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting
04/06/2024
- Novel CDK2/9 inhibitor fadraciclib induces anaphase catastrophe, a novel cancer-specific mechanism of action - BERKELEY HEIGHTS, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, [...]
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
04/06/2024
HOUSTON, June 04, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology [...]
Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting
04/06/2024
Overall response rate (ORR) of 46% and 12-month overall survival (OS) of 96% in first line (1L) recurrent/metastatic (R/M) HPV+ head and neck squamous cell carcinoma (HNSCC) treated with CUE-101 and KEYTRUDA ® ( [...]
The MUHC Foundation’s Le Bal Rouge Gala Raises a record-breaking $2,050,000 million for Cancer Research at the MUHC
04/06/2024
The MUHC Foundation backs the most innovative cancer researchers in the province. This year’s Le Bal Rouge gala supported the Cancer Research Program of the Research Institute of the McGill University Health Centre and [...]
Le Bal Rouge de la Fondation du CUSM recueille un montant record de 2,050,000 $ pour la recherche sur le cancer au CUSM
04/06/2024
La Fondation du CUSM soutient les chercheurs en oncologie les plus novateurs de la province. Le Bal Rouge appuyait cette année le programme de recherche sur le cancer de l’Institut de recherche du Centre universitaire [...]
Keros Therapeutics to Host a Corporate Update Conference Call and Webcast
04/06/2024
LEXINGTON, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization [...]
Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
04/06/2024
NEW HOPE, Pa., June 04, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk- [...]
Indaptus Therapeutics to Present New Positive Data on Decoy20 at Next-Gen Immuno-Oncology Conference
04/06/2024
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced [...]
4DMT Announces Presentations at Clinical Trials at the Summit 2024 Meeting
04/06/2024
• 24-week injection-free subgroup analyses from the Randomized Phase 2 Dose Expansion Stage of PRISM Trial Evaluating 4D-150 in wet AMD patients with severe disease activity and high treatment burden to be presented in [...]
Soleno Therapeutics Set to Join Russell 3000® Index
04/06/2024
REDWOOD CITY, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
Interpace Diagnostics Announces New Data Analyzing Imbalance of Short Tandem Repeat Alleles for Pancreatic Cancer Detection Published as an ASCO 2024 Abstract
04/06/2024
PARSIPPANY, NJ, June 04, 2024 (GLOBE NEWSWIRE) -- Interpace Diagnostics ® , a subsidiary of Interpace Biosciences ® (OTCQX: IDXG), is proud to announce that new data demonstrating the application of advanced sequencing [...]
Surplus Solutions Announces Major Expansion of Operations with New 37,000 Sq Ft Warehouse in Murrieta, CA
04/06/2024
WOONSOCKET, R.I., June 04, 2024 (GLOBE NEWSWIRE) -- Surplus Solutions, a leader in Equipment Lifecycle Management (ELM) services, announces the opening of a new, state-of-the-art 37,000 square foot warehouse in downtown [...]
MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances
04/06/2024
MOJO to be offered as an Oral Dissolvable Tablet (ODT) marketed to younger male demographic as an alternative to PRIME Testosterone Replacement Therapy (TRT) Dallas, Texas, June 04, 2024 (GLOBE NEWSWIRE) -- [...]
Apollomics Announces Vebreltinib Data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
04/06/2024
Data from Phase 2 and 2/3 trials demonstrate continued efficacy and safety of vebreltinib for treating different tumor types carrying MET-driver alterations FOSTER CITY, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- [...]
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/06/2024
RESEARCH TRIANGLE PARK, N.C., June 04, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 10 newly-hired [...]
Microbix Advances Test-Ingredient Manufacturing Capabilities
04/06/2024
Bioreactor Production of a Second Major Antigen – Increasing Capacity and Flexibility MISSISSAUGA, Ontario, June 04, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life [...]
Breckenridge Brewery Announces 'On Tap with KBCO' Concert Series Featuring Gary Clark Jr.
04/06/2024
Tickets Available Now and Through June 10th LITTLETON, Colo., June 04, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery (“Breck Brew”) , a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), and 97.3 KBCO ( [...]

Pages